Evidence map›Paper›PMID 31141415›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2019

Expression and function of nesfatin-1 are altered by stage of the estrous cycle.

Alicia T Pate, Abigayle L Schnell, Teresa A Ennis, Willis K Samson, Gina L C Yosten

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Looking Back on Seven Years ofAmerican journal of physiology. Regulatory, integrative and comparative physiology · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alicia T PateSaint Louis College of Pharmacy, St. Louis, Missouri.
Abigayle L SchnellDepartment of Pharmacology and Physiology, St. Louis University School of Medicine, St. Louis, Missouri.
Teresa A EnnisDepartment of Pharmacology and Physiology, St. Louis University School of Medicine, St. Louis, Missouri.
Willis K SamsonDepartment of Pharmacology and Physiology, St. Louis University School of Medicine, St. Louis, Missouri.ORCID 0000-0003-0560-4447
Gina L C YostenDepartment of Pharmacology and Physiology, St. Louis University School of Medicine, St. Louis, Missouri.
Saint Louis University · USUniversity of Health Sciences and Pharmacy · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nesfatin-1 is a peptide derived from the nucleobindin 2 (

Indexed as

AnimalsDNA-Binding ProteinsEstrous CycleFemaleHormonesHypothalamusMaleNerve Tissue ProteinsNucleobindinsPeptide HormonesRats, Sprague-DawleyReceptors, MelanocortinDNA-Binding ProteinsHormonesNerve Tissue ProteinsNucb2 protein, ratNucleobindinsPeptide HormonesReceptors, Melanocortinangiotensin IIcentral melanocortin systemmean arterial pressurenesfatin-1sex difference

Identifiers

PMID31141415
PMCPMC6732433
OpenAlexW2946848036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.